Skip to content
Recall Observatory FDA recall evidence

Drug product

Diltiazem HCl Extended-Release Capsules, USP 180mg, Packaged in a) 100-count bottles (NDC 0378-5280-01), and b) 500-count bottles (NDC 0378-5280-05), Rx only, Manufactured by: Mylan Pharmaceuticals Inc. Morgantown, WV, 26505

D-0506-2019

February 13, 2019

Class III

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 82086
Status
Terminated
Classification
Class III
Quantity
8,159 bottles
Official record key
drug-enforcement:D-0506-2019

Official wording

Reason: Failed Impurities/Degradation Specifications: High out of specification results obtained during routine stability testing

Code information: Lot #: 3090167, Exp. October 2019

Distribution pattern: Throughout the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification